Linike Medical Group Ltd. (LNMG)

Linike Medical Group Income Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Jul 31, 2014	Oct 31, 2013	Oct 31, 2012
Selling, General & Admin	0.09	0.21	0.1
Operating Expenses	0.3	0.43	0.1
Operating Income	-0.3	-0.43	-0.1
Other Non Operating Income (Expenses)	-0	-0	-
Pretax Income	-0.31	-0.43	-0.1
Net Income	-0.31	-0.43	-0.1
Net Income to Common	-0.31	-0.43	-0.1
Net Income Growth	-	-	-
Shares Outstanding (Basic)	3	2	0
Shares Outstanding (Diluted)	3	2	0
Shares Change	185.78%	535.30%	-
EPS (Basic)	-0.09	-0.25	-0.36
EPS (Diluted)	-0.09	-0.25	-0.36
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Jul 31, 2014	Oct 31, 2013	Oct 31, 2012
EBITDA	-0.3	-0.42	-
D&A For EBITDA	0	0	-
EBIT	-0.3	-0.43	-0.1

Data Source: S&P Global Market Intelligence Last updated: Sep 15, 2014

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error